Norges Bank’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,908,395
Closed -$692M 2111
2020
Q1
$692M Sell
3,908,395
-3,767
-0.1% -$709K 0.25% 75
2019
Q4
$748M Sell
3,912,162
-86,391
-2% -$15.6M 0.21% 90
2019
Q3
$673M Sell
3,998,553
-40,866
-1% -$6.66M 0.21% 90
2019
Q2
$676M Buy
4,039,419
+388,646
+11% +$53.8M 0.21% 90
2019
Q1
$535M Buy
3,650,773
+23,258
+0.6% +$3.37M 0.17% 115
2018
Q4
$485M Buy
3,627,515
+114,934
+3% +$18.8M 0.18% 110
2018
Q3
$669M Sell
3,512,581
-120,547
-3% -$22.1M 0.22% 89
2018
Q2
$606M Buy
3,633,128
+61,660
+2% +$9.9M 0.21% 90
2018
Q1
$601M Buy
3,571,468
+52,672
+1% +$8.83M 0.22% 94
2017
Q4
$576M Buy
3,518,796
+112,440
+3% +$20.2M 0.21% 102
2017
Q3
$698M Buy
3,406,356
+126,200
+4% +$29.3M 0.26% 70
2017
Q2
$797M Sell
3,280,156
-14,125
-0.4% -$3.32M 0.32% 57
2017
Q1
$787M Buy
3,294,281
+45,227
+1% +$10.5M 0.32% 55
2016
Q4
$682M Buy
3,249,054
+227,867
+8% +$47.2M 0.3% 61
2016
Q3
$665M Buy
3,021,187
+48,278
+2% +$11.8M 0.31% 61
2016
Q2
$687M Sell
2,972,909
-60,988
-2% -$14.1M 0.33% 55
2016
Q1
$813M Buy
3,033,897
+1,697
+0.1% +$486K 0.4% 45
2015
Q4
$948M Sell
3,032,200
-242,352
-7% -$72.2M 0.47% 42
2015
Q3
$890M Buy
+3,274,552
New +$1.01B 0.47% 41
2015
Q2
Sell
-2,938,413
Closed -$875M 2317
2015
Q1
$875M Buy
2,938,413
+1,173,244
+66% +$334M 0.43% 44
2014
Q4
$454M Sell
1,765,169
-24,595
-1% -$6.15M 0.23% 85
2014
Q3
$432M Sell
1,789,764
-545,184
-23% -$122M 0.23% 80
2014
Q2
$521M Buy
2,334,948
+1,190,698
+104% +$247M 0.14% 143
2014
Q1
$236M Hold
1,144,250
0.13% 151
2013
Q4
$192M Buy
1,144,250
+159,102
+16% +$24.9M 0.11% 187
2013
Q3
$142M Buy
985,148
+481,582
+96% +$64.2M 0.08% 234
2013
Q2
$63.6M Buy
+503,566
New +$57M 0.04% 442

Other funds holding AGN

Norges Bank's AGN Position: Q2 2020 in Review

Norges Bank sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,908,395 shares — an estimated $692M sold.

Norges Bank first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $948M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Norges Bank reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Norges Bank sold 3,908,395 Allergan plc shares in Q2 2020, an estimated $692M.
  • Norges Bank first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
  • Norges Bank's Allergan plc position peaked at $948M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Norges Bank's 13F filing for Q2 2020, filed 7 Aug 2020.